BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21763360)

  • 1. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.
    Re F; Cambianica I; Sesana S; Salvati E; Cagnotto A; Salmona M; Couraud PO; Moghimi SM; Masserini M; Sancini G
    J Biotechnol; 2011 Dec; 156(4):341-6. PubMed ID: 21763360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.
    Re F; Cambianica I; Zona C; Sesana S; Gregori M; Rigolio R; La Ferla B; Nicotra F; Forloni G; Cagnotto A; Salmona M; Masserini M; Sancini G
    Nanomedicine; 2011 Oct; 7(5):551-9. PubMed ID: 21658472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.
    Bana L; Minniti S; Salvati E; Sesana S; Zambelli V; Cagnotto A; Orlando A; Cazzaniga E; Zwart R; Scheper W; Masserini M; Re F
    Nanomedicine; 2014 Oct; 10(7):1583-90. PubMed ID: 24333591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.
    Salvati E; Re F; Sesana S; Cambianica I; Sancini G; Masserini M; Gregori M
    Int J Nanomedicine; 2013; 8():1749-58. PubMed ID: 23674890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.
    Taylor M; Moore S; Mourtas S; Niarakis A; Re F; Zona C; La Ferla B; Nicotra F; Masserini M; Antimisiaris SG; Gregori M; Allsop D
    Nanomedicine; 2011 Oct; 7(5):541-50. PubMed ID: 21722618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.
    Sauer I; Dunay IR; Weisgraber K; Bienert M; Dathe M
    Biochemistry; 2005 Feb; 44(6):2021-9. PubMed ID: 15697227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells.
    Markoutsa E; Papadia K; Clemente C; Flores O; Antimisiaris SG
    Eur J Pharm Biopharm; 2012 May; 81(1):49-56. PubMed ID: 22386910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid β1-42 peptide.
    Airoldi C; Mourtas S; Cardona F; Zona C; Sironi E; D'Orazio G; Markoutsa E; Nicotra F; Antimisiaris SG; La Ferla B
    Eur J Med Chem; 2014 Oct; 85():43-50. PubMed ID: 25072875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide.
    Kuo YC; Lin CY
    J Drug Target; 2015 Feb; 23(2):147-58. PubMed ID: 25268274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept.
    Papadia K; Markoutsa E; Mourtas S; Giannou AD; La Ferla B; Nicotra F; Salmona M; Klepetsanis P; Stathopoulos GT; Antimisiaris SG
    Eur J Pharm Sci; 2017 Apr; 101():140-148. PubMed ID: 28193538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
    Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
    Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease.
    Mourtas S; Lazar AN; Markoutsa E; Duyckaerts C; Antimisiaris SG
    Eur J Med Chem; 2014 Jun; 80():175-83. PubMed ID: 24780594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease.
    Mancini S; Minniti S; Gregori M; Sancini G; Cagnotto A; Couraud PO; Ordóñez-Gutiérrez L; Wandosell F; Salmona M; Re F
    Nanomedicine; 2016 Jan; 12(1):43-52. PubMed ID: 26410276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
    Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
    Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin interacts with apolipoprotein E and beta-amyloid and influences their crosstalk.
    Spagnuolo MS; Maresca B; La Marca V; Carrizzo A; Veronesi C; Cupidi C; Piccoli T; Maletta RG; Bruni AC; Abrescia P; Cigliano L
    ACS Chem Neurosci; 2014 Sep; 5(9):837-47. PubMed ID: 25058565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease.
    Pillot T; Goethals M; Najib J; Labeur C; Lins L; Chambaz J; Brasseur R; Vandekerckhove J; Rosseneu M
    J Neurochem; 1999 Jan; 72(1):230-7. PubMed ID: 9886074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.